Pune, Feb. 11, 2020 (GLOBE NEWSWIRE) -- The global Regenerative Medicine Market size projected to reach USD 151,949.5 million by the end of 2026. Product applications in the treatment of chronic diseases will provide impetus to market growth. According to a report published by Fortune Business Insights, titled “Regenerative Medicine Market Size, Share and Industry Analysis by Product (Cell Therapy, Gene Therapy, Tissue Engineering, Platelet Rich Plasma), By Application (Orthopaedics, Wound Care, Oncology), By Distribution Channel (Hospitals, Clinics) & Regional Forecast, 2019 - 2026,” the market was valued at USD 23,841.5 million in 2018. And will exhibit a CAGR of 26.1% during the forecast period, 2019-2026.


For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/regenerative-medicine-market-100970


Product Overview:

Regenerative medicine is used to replace human cells and organs within the human body. The product is used to repair damaged tissues in the human body without affecting neighbouring undesired tissues. Recent molecular advances in manufacturing of regenerative medicine have allowed widespread applications and subsequently led to high product demand in several countries across the world. Ongoing studies in regenerative medicine have indicated a promising future, accounting to breakthrough concepts and its potential to cure severe disorders as well as diseases that were initially incurable. The growing emphasis on the research and development of newer products, coupled with the high investments in bettering existing products, will have a positive impact on the growth of the market in the coming years.

Report Overview:

The report provides an in-depth analysis of the global regenerative medicine market. It highlights the latest product launches and recent innovations in the market and states their impact on the growth of the market. Forecast values have been provided for the market for the period of 2019-2026. The factual figures have been obtained through trusted sources. Moreover, these predictions are made on the basis of extensive research analysis methods, coupled with the opinions of experienced market research professionals. The competitive landscape has been discussed in detail and predictions are made with respect to leading companies and products in the coming years.


Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/regenerative-medicine-market-100970


Increasing Number of Regulatory Approvals Will Aid Growth

The report encompasses several factors that have contributed to the growth of the market in recent years. Among all factors, the increasing number of regulatory approvals has made the highest impact on the growth of the market. Several large scale companies are engaged in developing newer products associated with regenerative medicine. Regulatory clearances will boost the commercialization of these products. In 2018, Novartis received approval from the European Union for its latest regenerative medicine ‘Luxturna’. The company claims that this drug can be used to treat and restore sight for people with vision impairment. Novartis’ latest advancement will not only help the company grow, but will have a direct impact on the growth of the market in the forthcoming years.

Asia Pacific to Register Comparatively High CAGR; Extensive Studies in Product R&D Will Aid Growth

The report analyzes ongoing regenerative medicine market trends across North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. Among these regions, the market in Asia Pacific will witness a high CAGR in the coming years, driven by the efforts put in to develop newer products by major companies. The increasing incidence of chronic diseases in several countries across this region will open up a huge potential for market growth. Besides Asia Pacific, the market in North America will witness considerable growth owing to presence of several large scale companies. As of 2018, the market in North America was worth USD 9128.2 million and this value is projected to increase further in the coming years.

List of the leading companies that are operating in the global regenerative medicine market are:

  • Integra LifeSciences Corporation
  • CELGENE CORPORATION
  • Medtronic
  • American CryoStem Corporation
  • Tissue Regenix
  • Avita Medical
  • Osiris Therapeutics, Inc.
  • Wright Medical Group N.V.
  • Smith & Nephew

Noteworthy Industry Developments:
2017: Integra LifeSciences announced the launch of Integra Dermal Regeneration Template Single Layer "Thin", a product used for dermal repair defects in reconstruction.


Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/regenerative-medicine-market-100970


Detailed Table of Content:

  • Introduction
    • Research Scope
    • Market Segmentation
    • Research Methodology
    • Definitions and Assumptions
  • Executive Summary
  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Key Insights
    • Prevalence and incidence of diabetes, by key countries
    • Advancements in insulin delivery devices
    • Pricing Analysis, by key players
    • Technological Advancements
    • Key mergers & acquisitions, by key players
  • Global Regenerative Medicine Market Analysis, Insights and Forecast, 2015-2026
    • Key Findings / Summary
    • Market Analysis, Insights and Forecast – By Product
      • Cell Therapy
      • Gene Therapy
      • Tissue Engineering
      • Platelet Rich Plasma
    • Market Analysis, Insights and Forecast – By Application
      • Orthopedics
      • Wound Care
      • Oncology
      • Others
    • Market Analysis, Insights and Forecast – By Distribution Channel
      • Hospitals
      • Clinics
      • Others
    • Market Analysis, Insights and Forecast – By Region
      • North America
      • Europe
      • Asia pacific
      • Latin America
      • Middle East & Africa

TOC Continued….!


Request for Customization: https://www.fortunebusinessinsights.com/enquiry/customization/regenerative-medicine-market-100970


Have a Look at Related Reports:

Molecular Diagnostics Market Size, Share and Global Trend By Product Type (Instruments Reagents & Consumables), Application (Infectious Disease, Blood Screening, Histology & Oncology), Technique (Hospitals Amplification, Hybridization & Sequencing Techniques), End User (Hospitals, Clinical & Pathology Labs) and Geography Forecast till 2025

Genomics Market Size, Share and Global Trend By Type (Products, Services), Technology (Polymerase Chain Reaction, Next-generation Sequencing, Microarray, Sanger Sequencing), Application (Diagnostics, Research), End-User (Research Institutes, Healthcare Facilities & Diagnostic Centers, Pharmaceutical & Biotechnological Companies, Contract Research Organization (CROs)) & Geography Forecast till 2026

Next-Generation Sequencing (NGS) Market Size, Share and Global Trend By Type (Products, Instruments & Software, Consumables, Services), By Application (Diagnostics, Research), By End User (Research Institutes, Healthcare Facilities & Diagnostic Centres, Pharmaceutical & Biotechnological Companies, Contract Research Organization) & Geography Forecast till 2026

Telemedicine Market Size, Share and Global Trend By Type (Products, Services), By Application (Teleradiology, Telepathology, Teledermatology, Telepsychiatry, Telecardiology, Others), By Modality (Store-and-forward (Asynchronous) , Real-time (Synchronous), Others) and Geography Forecast till 2026

Advanced Wound Care Market Size, Share and Industry Analysis, By Product (Advanced Wound Dressings, Wound Care Devices & Active Wound Care), By Indication (Diabetic Foot Ulcers, Pressure Ulcers, Surgical Wounds, Others), By End User, and Regional Forecast 2018-2025

Orphan Drugs Market Size, Share and Industry Analysis By Therapy Area (Oncology, Blood, CNS, Endocrine, Cardiovascular, Respiratory, Immunomodulatory), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Sales) and Regional Forecast, 2018 - 2025

Dialyzer Market Size, Share and Industry Analysis by Flux Type (High-flux, Low-Flux), By Usage Type (Disposable, Reusable), By End User (Dialysis Centers and Hospitals, Home Healthcare), and Regional Forecast, 2019 – 2026

Thrombin Market Size, Share and Industry Analysis By Product (Bovine Thrombin, Human Thrombin, Recombinant Thrombin), By Dosage Form (Powder Form, Solution Form), By End user (Hospitals, Diagnostics Centers & Clinics, Academics and Research Institutes), and Regional Forecast, 2019 – 2026

About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:
Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.
Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
Fortune Business Insights™
LinkedIn | Twitter | Blogs

Press Release https://www.fortunebusinessinsights.com/press-release/stomach-gastric-cancer-treatment-market-9572